A study on CD19-deficient (CD19−/−) mice sensitized by ovalbumin exhibited a histologically weaker AD phenotype along with a lower proliferation of antigen-specific CD4+ T cells and less secretion of Th2 and Th17 cytokines compared to wild type mice. This evidence concerns the gene CD19 and Alzheimer disease.